Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism CCR7 inhibitors(C-C motif chemokine receptor 7 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Fibrosis | Preclinical | JP | 31 Oct 2024 | |
Renal fibrosis | Preclinical | JP | 31 Oct 2024 |